Broadening our horizons: Gene expression profiling to help better understand the neurobiology of suicide and depression

Neurobiology of Disease

Volumn 45, Issue 1, 2012, Pages 14-22

  Fiori, Laura M ^a   Turecki, Gustavo ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Gene expression; Major depression; Microarray; Suicide

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID CARRIER; 4 AMINOBUTYRIC ACID RECEPTOR; AGMATINE; BRAIN DERIVED NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR; GLUTAMIC ACID; NEUROTROPHIN; POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMINE;

AUTOPSY; BIOTECHNOLOGY; BRAIN TISSUE; DEPRESSION; GABAERGIC TRANSMISSION; GENE EXPRESSION PROFILING; GLIA CELL; HUMAN; METHODOLOGY; MICROARRAY ANALYSIS; NEUROBIOLOGY; NEUROPATHOLOGY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK FACTOR; SAMPLE SIZE; SAMPLING; STATISTICAL ANALYSIS; SUICIDE; SYNAPSE VESICLE; VALIDATION PROCESS;

DEPRESSIVE DISORDER; GENE EXPRESSION PROFILING; HUMANS; PREFRONTAL CORTEX; SUICIDE;

EID: 81955167659     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.11.004     Document Type: Review

References (95)

1. Altar C.A., Jurata L.W., Charles V., Lemire A., Liu P., Bukhman Y., et al. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol. Psychiatry 2005, 58(2):85-96.
2. Altar C.A., Vawter M.P., Ginsberg S.D. Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology 2009, 34(1):18-54.
3. Araque A. Astrocytes process synaptic information. Neuron Glia Biol. 2008, 4(1):3-10.
4. Arsenault-Lapierre G., Kim C., Turecki G. Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry 2004, 4:37.
5. Aston C., Jiang L., Sokolov B.P. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol. Psychiatry 2005, 10(3):309-322.
6. Auer H., Lyianarachchi S., Newsom D., Klisovic M.I., Marcucci U., Kornacker K. Chipping away at the chip bias: RNA degradation in microarray analysis. Nat. Genet. 2003, 35(4):292-293.
7. Bachis A., Mallei A., Cruz M.I., Wellstein A., Mocchetti I. Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons. Neuropharmacology 2008, 55(7):1114-1120.
8. Bak L.K., Schousboe A., Waagepetersen H.S. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J. Neurochem. 2006, 98(3):641-653.
9. Barley K., Dracheva S., Byne W. Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophr. Res. 2009, 112(1-3):54-64.
10. Bernard, R., Kerman, I.A., Thompson, R.C., Jones, E.G., Bunney, W.E., Barchas, J.D., et al., in press. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol. Psychiatry.
11. Brent D.A., Bridge J., Johnson B.A., Connolly J. Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch. Gen. Psychiatry 1996, 53(12):1145-1152.
12. Brezo J., Klempan T., Turecki G. The genetics of suicide: a critical review of molecular studies. Psychiatr. Clin. North Am. 2008, 31(2):179-203.
13. Brunoni A.R., Lopes M., Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 2008, 11(8):1169-1180.
14. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 2001, 50(4):260-265.
15. Choudary P.V., Molnar M., Evans S.J., Tomita H., Li J.Z., Vawter M.P., et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(43):15653-15658.
16. Chu T.T., Liu Y., Kemether E. Thalamic transcriptome screening in three psychiatric states. J. Hum. Genet. 2009, 54(11):665-675.
17. Cook E.H., Scherer S.W. Copy-number variations associated with neuropsychiatric conditions. Nature 2008, 455(7215):919-923.
18. Daikhin Y., Yudkoff M. Compartmentation of brain glutamate metabolism in neurons and glia. J. Nutr. 2000, 130(4S Suppl.):1026S-1031S.
19. Deng W., Poretz R.D. Oligodendroglia in developmental neurotoxicity. Neurotoxicology 2003, 24(2):161-178.
20. Ernst C., Bureau A., Turecki G. Application of microarray outlier detection methodology to psychiatric research. BMC Psychiatry 2008, 8:29.
21. Ernst C., Deleva V., Deng X., Sequeira A., Pomarenski A., Klempan T., et al. Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch. Gen. Psychiatry 2009, 66(1):22-32.
22. Ernst C., Mechawar N., Turecki G. Suicide neurobiology. Prog. Neurobiol. 2009, 89(4):315-333.
23. Evans S.J., Choudary P.V., Neal C.R., Li J.Z., Vawter M.P., Tomita H., et al. Dysregulation of the fibroblast growth factor system in major depression. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(43):15506-15511.
24. Fiacco T.A., Agulhon C., McCarthy K.D. Sorting out astrocyte physiology from pharmacology. Annu. Rev. Pharmacol. Toxicol. 2009, 49:151-174.
25. Fiori L.M., Turecki G. Implication of the polyamine system in mental disorders. J. Psychiatry Neurosci. 2008, 33(2):102-110.
26. Fiori L.M., Turecki G. Association of the SAT1 In/del polymorphism with suicide completion. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 153B(3):825-829.
27. Fiori, L.M., Zouk, H., Himmelman, C., Turecki, G., in press. X Chromosome and suicide. Mol. Psychiatry.
28. Gadbury G.L., Garrett K.A., Allison D.B. Challenges and approaches to statistical design and inference in high-dimensional investigations. Meth. Mol. Biol. 2009, 553:181-206.
29. Gaiteri C., Guilloux J.P., Lewis D.A., Sibille E. Altered gene synchrony suggests a combined hormone-mediated dysregulated state in major depression. PLoS ONE 2010, 5(4):e9970.
30. Garbett K., Gal-Chis R., Gaszner G., Lewis D.A., Mirnics K. Transcriptome alterations in the prefrontal cortex of subjects with schizophrenia who committed suicide. Neuropsychopharmacol. Hung. 2008, 10(1):9-14.
31. Gehrmann J., Matsumoto Y., Kreutzberg G.W. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Brain Res. Rev. 1995, 20(3):269-287.
32. Gilad G.M., Gilad V.H. Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival. Cell. Mol. Neurobiol. 2003, 23(4-5):637-649.
33. Glatt S.J., Everall I.P., Kremen W.S., Corbeil J., Sasik R., Khanlou N., et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(43):15533-15538.
34. Guipponi M., Deutsch S., Kohler K., Perroud N., Le Gal F., Vessaz M., et al. Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal behavior. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B(6):799-807.
35. Gwadry F.G., Sequeira A., Hoke G., Ffrench-Mullen J.M., Turecki G. Molecular characterization of suicide by microarray analysis. Am. J. Med. Genet. C Semin. Med. Genet. 2005, 133C(1):48-56.
36. Hawton K. Sex and suicide. Gender differences in suicidal behaviour. Br. J. Psychiatry 2000, 177:484-485.
37. Hercher C., Turecki G., Mechawar N. Through the looking glass: examining neuroanatomical evidence for cellular alterations in major depression. J. Psychiatr. Res. 2009, 43(11):947-961.
38. Hynd M.R., Lewohl J.M., Scott H.L., Dodd P.R. Biochemical and molecular studies using human autopsy brain tissue. J. Neurochem. 2003, 85(3):543-562.
39. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4(2):249-264.
40. Iwamoto K., Kato T. Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist 2006, 12(4):349-361.
41. Iwamoto K., Kakiuchi C., Bundo M., Ikeda K., Kato T. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol. Psychiatry 2004, 9(4):406-416.
42. Kang H.J., Adams D.H., Simen A., Simen B.B., Rajkowska G., Stockmeier C.A., et al. Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J. Neurosci. 2007, 27(48):13329-13340.
43. Karssen A.M., Her S., Li J.Z., Patel P.D., Meng F., Bunney W.E., et al. Stress-induced changes in primate prefrontal profiles of gene expression. Mol. Psychiatry 2007, 12(12):1089-1102.
44. Kim S., Webster M.J. Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol. Psychiatry 2010, 15(3):326-336.
45. Kim S., Webster M.J. The Stanley Neuropathology Consortium Integrative Database: a novel, web-based tool for exploring neuropathological markers in psychiatric disorders and the biological processes associated with abnormalities of those markers. Neuropsychopharmacology 2010, 35(2):473-482.
46. Kim C., Lesage A., Seguin M., Chawky N., Vanier C., Lipp O., et al. Patterns of co-morbidity in male suicide completers. Psychol. Med. 2003, 33(7):1299-1309.
47. Kim S., Choi K.H., Baykiz A.F., Gershenfeld H.K. Suicide candidate genes associated with bipolar disorder and schizophrenia: an exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMC Genomics 2007, 8:413.
48. Klempan T.A., Ernst C., Deleva V., Labonte B., Turecki G. Characterization of QKI gene expression, genetics, and epigenetics in suicide victims with major depressive disorder. Biol. Psychiatry 2009, 66(9):824-831.
49. Klempan T.A., Rujescu D., Merette C., Himmelman C., Sequeira A., Canetti L., et al. Profiling brain expression of the spermidine/spermine N(1)-acetyltransferase 1 (SAT1) gene in suicide. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B(7):934-943.
50. Klempan T.A., Sequeira A., Canetti L., Lalovic A., Ernst C., Ffrench-Mullen J., et al. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol. Psychiatry 2009, 14(2):175-189.
51. Koehler R.C., Roman R.J., Harder D.R. Astrocytes and the regulation of cerebral blood flow. Trends Neurosci. 2009, 32(3):160-169.
52. Lalovic A., Klempan T., Sequeira A., Luheshi G., Turecki G. Altered expression of lipid metabolism and immune response genes in the frontal cortex of suicide completers. J. Affect. Disord. 2010, 120(1-3):24-31.
53. Law A.J., Deakin J.F.W. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. NeuroReport 2001, 12(13):2971-2974.
54. McGirr A., Turecki G. What is specific to suicide in schizophrenia disorder? Demographic, clinical and behavioural dimensions. Schizophr. Res. 2008, 98(1-3):217-224.
55. McGirr A., Seguin M., Renaud J., Benkelfat C., Alda M., Turecki G. Gender and risk factors for suicide: evidence for heterogeneity in predisposing mechanisms in a psychological autopsy study. J. Clin. Psychiatry 2006, 67(10):1612-1617.
56. McGirr A., Paris J., Lesage A., Renaud J., Turecki G. Risk factors for suicide completion in borderline personality disorder: a case-control study of cluster B comorbidity and impulsive aggression. J. Clin. Psychiatry 2007, 68(5):721-729.
57. McGirr A., Alda M., Seguin M., Cabot S., Lesage A., Turecki G. Familial aggregation of suicide explained by cluster B traits: a three-group family study of suicide controlling for major depressive disorder. Am. J. Psychiatry 2009, 166(10):1124-1134.
58. McGowan P.O., Sasaki A., Huang T.C., Unterberger A., Suderman M., Ernst C., et al. Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS ONE 2008, 3(5):e2085.
59. McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonte B., Szyf M., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 2009, 12(3):342-348.
60. Merali Z., Du L., Hrdina P., Palkovits M., Faludi G., Poulter M.O., et al. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J. Neurosci. 2004, 24(6):1478-1485.
61. Minguet E.G., Vera-Sirera F., Marina A., Carbonell J., Blazquez M.A. Evolutionary diversification in polyamine biosynthesis. Mol. Biol. Evol. 2008, 25(10):2119-2128.
62. Miron M., Nadon R. Inferential literacy for experimental high-throughput biology. Trends Genet. 2006, 22(2):84-89.
63. Montana V., Malarkey E.B., Verderio C., Matteoli M., Parpura V. Vesicular transmitter release from astrocytes. Glia 2006, 54(7):700-715.
64. Morita K., Saito T., Ohta M., Ohmori T., Kawai K., Teshima-kondo S., et al. Expression analysis of psychological stress-associated genes in peripheral blood leukocytes. Neurosci. Lett. 2005, 381(1-2):57-62.
65. Moussavi S., Chatterji S., Verdes E., Tandon A., Patel V., Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007, 370(9590):851-858.
66. Nock M.K., Borges G., Bromet E.J., Cha C.B., Kessler R.C., Lee S. Suicide and suicidal behavior. Epidemiol. Rev. 2008, 30:133-154.
67. O'Kusky J., Colonnier M. A laminar analysis of the number of neurons, glia, and synapses in the adult cortex (area 17) of adult macaque monkeys. J. Comp. Neurol. 1982, 210(3):278-290.
68. Ornitz D.M., Itoh N. Fibroblast growth factors. Genome Biol. 2001, 2(3). (REVIEWS3005).
69. Pawson T. Tyrosine kinase signalling pathways. Princess Takamatsu Symp. 1994, 24:303-322.
70. Pfrieger F.W. Roles of glial cells in synapse development. Cell. Mol. Life Sci. 2009, 66(13):2037-2047.
71. Poulter M.O., Du L., Zhurov V., Palkovits M., Faludi G., Merali Z., et al. Altered organization of GABA(A) receptor mRNA expression in the depressed suicide brain. Front. Mol. Neurosci. 2010, 3:3.
72. Rhee H.J., Kim E.J., Lee J.K. Physiological polyamines: simple primordial stress molecules. J. Cell. Mol. Med. 2007, 11(4):685-703.
73. Seedat S., Scott K.M., Angermeyer M.C., Berglund P., Bromet E.J., Brugha T.S., et al. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch. Gen. Psychiatry 2009, 66(7):785-795.
74. Segman R.H., Goltser-Dubner T., Weiner I., Canetti L., Galili-Weisstub E., Milwidsky A., et al. Blood mononuclear cell gene expression signature of postpartum depression. Mol. Psychiatry 2010, 15(1):93-100. (2).
75. Seiler N., Raul F. Polyamines and apoptosis. J. Cell. Mol. Med. 2005, 9(3):623-642.
76. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 2008, 64(6):527-532.
77. Sequeira A., Turecki G. Genome wide gene expression studies in mood disorders. OMICS 2006, 10(4):444-454.
78. Sequeira A., Gwadry F.G., Ffrench-Mullen J.M., Canetti L., Gingras Y., Casero R.A., et al. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch. Gen. Psychiatry 2006, 63(1):35-48.
79. Sequeira A., Klempan T., Canetti L., Ffrench-Mullen J., Benkelfat C., Rouleau G.A., et al. Patterns of gene expression in the limbic system of suicides with and without major depression. Mol. Psychiatry 2007, 12(7):640-655.
80. Sequeira A., Mamdani F., Ernst C., Vawter M.P., Bunney W.E., Klempan T., et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS ONE 2009, 4(8):e6585.
81. Sequeira A., Mamdani F., Ernst C., Vawter M.P., Bunney W.E., Klempan T., et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS ONE 2009, 4(8):e6585.
82. Shelton, R.C., Claiborne, J., Sidoryk-Wegrzynowicz, M., Reddy, R., Aschner, M., Lewis, D.A., et al., in press. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol. Psychiatry.
83. Sibille E., Arango V., Galfalvy H.C., Pavlidis P., Erraji-Benchekroun L., Ellis S.P., et al. Gene expression profiling of depression and suicide in human prefrontal cortex. Neuropsychopharmacology 2004, 29(2):351-361.
84. Sibille E., Wang Y., Joeyen-Waldorf J., Gaiteri C., Surget A., Oh S., et al. A molecular signature of depression in the amygdala. Am. J. Psychiatry 2009, 166(9):1011-1024.
85. Spijker S., Van Zanten J.S., De Jong S., Penninx B.W.J.H., Van Dyck R., Zitman F.G., et al. Stimulated gene expression profiles as a blood marker of major depressive disorder. Biol. Psychiatry 2010, 68(2):179-186.
86. Statham D.J., Heath A.C., Madden P.A., Bucholz K.K., Bierut L., Dinwiddie S.H., et al. Suicidal behaviour: an epidemiological and genetic study. Psychol. Med. 1998, 28(4):839-855.
87. Steinhoff C., Vingron M. Normalization and quantification of differential expression in gene expression microarrays. Brief. Bioinform. 2006, 7(2):166-177.
88. Stevens B. Neuron-astrocyte signaling in the development and plasticity of neural circuits. Neurosignals 2008, 16(4):278-288.
89. Tabor C.W., Tabor H. Polyamines. Annu. Rev. Biochem. 1984, 53:749-790.
90. Thalmeier A., Dickmann M., Giegling I., Schneider B., Hartmann M., Maurer K., et al. Gene expression profiling of post-mortem orbitofrontal cortex in violent suicide victims. Int. J. Neuropsychopharmacol. 2008, 11(2):217-228.
91. Tochigi M., Iwamoto K., Bundo M., Sasaki T., Kato N., Kato T. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci. Res. 2008, 60(2):184-191.
92. Uezato A., Meador-Woodruff J.H., McCullumsmith R.E. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia. Bipolar Disord. 2009, 11(7):711-725.
93. Vawter M.P., Tomita H., Meng F., Bolstad B., Li J., Evans S., et al. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol. Psychiatry 2006, 11(7):663-679.
94. Yanagi M., Shirakawa O., Kitamura N., Okamura K., Sakurai K., Nishiguchi N., et al. Association of 14-3-3 epsilon gene haplotype with completed suicide in Japanese. J. Hum. Genet. 2005, 50(4):210-216.
95. Zhang T.Y., Meaney M.J. Epigenetics and the environmental regulation of the genome and its function. Annu. Rev. Psychol. 2010, 61:439-466.